Integrating Clinical and Patient Perspectives: Latest Developments in Exercise and Lifestyle Intervention for MASLD/MASH Management

Integrating Clinical and Patient Perspectives: Latest Developments in Exercise and Lifestyle Intervention for MASLD/MASH Management | Recording

Recorded Webinar

Register for a 2-speaker recorded webinar to learn about the latest clinical and patient-centered approaches to MASLD and MASH management through exercise and lifestyle interventions.

Overview

Register for a 2-speaker recorded webinar to learn about the latest clinical and patient-centered approaches to MASLD and MASH management through exercise and lifestyle interventions. Our speakers review the latest evidence supporting exercise and lifestyle interventions, clinical strategies for implementation of these interventions. Furthermore, they discuss the importance of comprehensive care teams and share first-hand patient experiences in MASLD and MASH management for improving long-term outcomes.

Learning Objectives

Speaker 1 (Dr. Stine):

To understand the latest clinical evidence supporting exercise and lifestyle interventions in the management of MASLD/MASH and their impact on liver-related and metabolic outcomes
Identify key clinical strategies for implementing exercise and lifestyle modifications in patients with MASLD/MASH, including the role of personalized interventions
To evaluate the practical challenges and opportunities in translating recent research findings into everyday clinical practice for improving MASLD/MASH management through exercise and lifestyle changes.

Speaker 2 (Ms. Sivia):

To share objectives based on my personal experience as well as information shared with me through the care of my hepatologist, who is the leader of my care team:
- Comprehensive care: who needs to be on the patient’s team (hematologist, endocrinologist, registered dietitian nutritionist), and why that matters to the patient.
- The feeling your patients might have after diagnosis, questions your patients might have, and how to provide resources for successful treatment. The things your patients don’t know they need to know… and questions they have but won’t ask due to fear, embarrassment, or other factors.
- How lifestyle changes are made: The importance of diet, exercise, and breaking change down into realistic, achievable pieces. Using educational and digital tools to help reach success. Reiterating that even with medication and new MASLD treatments, patients do best when they eat right and exercise… and maintain mental health, too. These are the keys to successful treatment and a longer life. What dieting and exercise look and feel like in real life vs in magazines, on TV, or on the internet. Hope exists for everyone!

Faculty

Jonathan G. Stine, MD, MSc, FACP

Dr. Jonathan Stine is an Associate Professor of Medicine and Public Health Science at Penn State. As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD) and exercise, he has authored more than 110 peer-reviewed papers, including multinational consensus guidelines, and several book chapters. Dr. Stine has been the recipient of multiple research grants and awards from the American Association for the Study of Liver Diseases, American Cancer Society and National Institutes of Health. He has been a study investigator on over 30 MASLD clinical trials and is on the editorial board for several leading hepatology journals. Dr. Stine is the MASLD consultant to the American College of Sports Medicine’s Exercise is Medicine initiative and recently co-chaired the International Roundtable on MASLD and Physical Activity for ACSM. In addition to his scholarly work, Dr. Stine serves as the Fatty Liver Program Director as well as the Research Director for Penn State Health Liver Center. He is a founding member of the METCon (MASLD Exercise Training Consortium), a multinational consortium of exercise researchers. When not at work, he can be found doing anything and everything physically active and enjoys running, resistance training, cycling, yoga, pickleball, kayaking, snowboarding and more!

Kerry Sivia, BA

In 2021, I was diagnosed with MASLD/MASH, autoimmune hepatitis, primary biliary cholangitis, and cirrhosis. This news propelled me on a journey of learning and adaptation, guided by the expertise of my hepatologist, endocrinologist and dietitian. Together, we've embraced medication and lifestyle changes, including losing 110 pounds, which has helped eliminate the fat in my liver. It has. Also helped to slow or even stop the disease’s progression. I've faced challenges and victories on my journey, and I try to continually improve. Inspired by my medical team as well as the hepatology, endocrinology and dietetics communities, I strive to be a model patient. My central goal is to continually improve patient outcomes through education and advocacy.

Dr. Shelley Keating, PhD, AES, AEP
School of Human Movement and Nutrition Sciences
The University of Queensland, Brisbane, Australia

Dr. Shelley Keating is an Accredited Exercise Physiologist and Senior Lecturer in Clinical Exercise Physiology within the School of Human Movement and Nutrition Science at The University of Queensland. She leads a program of research that aims to change the way we access and prioritize exercise for the management of cardiometabolic disease, notably metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes. Her research has led to the development of safe and feasible exercise programs that generate significant improvement in the cardiometabolic health of individuals with MASLD and related chronic disease.

Summary

Availability:

On-Demand

Cost:

FREE

Credit Offered:

No Credit Offered

Create Account